Analysis of Correlation of Insulin Resistance With Incidence and Recurrence of Colorectal Adenoma
10.3969/j.issn.1008-7125.2018.10.007
- VernacularTitle:胰岛素抵抗与结直肠腺瘤发生和复发的相关性分析
- Author:
Lei ZONG
1
;
Wei WANG
;
Shilin QIU
;
Xinling ZHOU
;
Shanming SUN
Author Information
1. 潍坊市人民医院消化内科 261000
- Keywords:
Colorectal Adenoma;
Insulin Resistance;
Recurrence;
Metabolic Syndrome X
- From:
Chinese Journal of Gastroenterology
2018;23(10):606-610
- CountryChina
- Language:Chinese
-
Abstract:
Background:Reduction of incidence and recurrence rates of colorectal adenoma (CRA)are the keys for reducing the incidence of colorectal cancer. Studies have shown that insulin resistance is involved in this process. Aims:To investigate the correlation of insulin resistance with incidence and recurrence of CRA. Methods:Clinical data of 238 CRA patients were collected,and 200 patients with normal colonoscopy results were served as controls. Waist to hip ratio (WHR), fasting blood glucose (FPG),total cholesterol (TC),triglyceride (TG),high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C),adiponectin,fasting insulin (FINS),HOMA-IR were compared between the two groups. Correlation of insulin resistance with incidence and recurrence of CRA was analyzed. Results:WHR,FPG, TG,FINS,adiponectin and HOMA-IR were statistically different between CRA group and controls (P＜0.05),however, no significant differences in BMI,DBP,TC,HDL-C,LDL-C were found between the two groups. Incidence rate of CRA (80.1% vs. 41.4%)and recurrence rate of CRA (62.4% vs. 46.3%)were significantly increased in patients with insulin resistance than those in patients without insulin resistance. Logistic regression analysis showed that family history, metabolic syndrome and HOMA-IR were independent risk factors for incidence of CRA (P ＜0. 05 ),and metabolic syndrome,family history of adenoma,adenoma number,adenoma size,pathological type and HOMA-IR were independent risk factors for recurrence of CRA (P＜0.05). Conclusions:The incidence and recurrence rates of CRA are higher in patients with insulin resistance than those without insulin resistance.
